entertainment -WSS

entertainment

author：comprehensive 2025-09-02 11:43:18 - browse：95925

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： NIH nominee Bertagnolli will get October confirmation hearing

WSS

How to protect patients from sexual assault

There’s a way to spot data fakery. All journals should be using it

Delta passengers in Vegas fall sick while waiting on flight in triple

Mystery swirls around US soldier who entered North Korea days ago, officials say

What American doctors can learn from their Israeli counterparts

Hormonal contraceptives don’t actually treat endometriosis

entertainment

entertainment

focus

Medical records are filled with copy

Stem cell treatment guidelines are released by FDA

State Dept. review finds Biden bears some blame for Afghanistan failures

House transparency, PBM reform bill gains bipartisan support

Virginia high school admissions case could be legal follow

Stem cell treatment guidelines are released by FDA

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Apple is now the first public company to be valued at $3 trillion

How a Boston hospital is priming medical residents to use GPT

knowledge

In rare move, senator releases unverified FBI source report alleging Biden bribe

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

After a decade, new Gardasil ad campaign gets it (mostly) right

Why Novartis is changing the name of its research labs

Dementia risk linked to living in disadvantaged areas: Study

How to fix cancer clinical trials' diversity problem

Wikipedia

entertainment

focus

explore